A case series of pediatric COVID-19 with complicated symptoms in Iran [0.03%]
伊朗儿童期COVID-19的复杂症状系列病例研究
Fatemeh Cheraghali,Leila Barati,Dayan Amanian et al.
Fatemeh Cheraghali et al.
People in different age groups are susceptible to SARS-CoV-2 infection as a newly emerging virus. However, the clinical course, symptoms and disease outcome vary from case to case. Although COVID-19 is usually milder in children than adults...
Association between blood groups and COVID-19 outcome in Iranian patients [0.03%]
血型与伊朗COVID-19患者病情之间的相关性研究
Ali Asghar Ayatollahi,Bahman Aghcheli,Abolfazl Amini et al.
Ali Asghar Ayatollahi et al.
Aim: Many factors have been speculated to explain the COVID-19 complex clinical phenotype. Due to the inconsistent data published on blood groups and COVID-19, we conducted a study on Iranian patients to further assess this association. Mat...
High-value laboratory testing for hospitalized COVID-19 patients: a review [0.03%]
住院COVID-19患者的高价值实验室检测：一项综述
Daniela Cihakova,Michael B Streiff,Steven P Menez et al.
Daniela Cihakova et al.
We present here an evidence-based review of the utility, timing, and indications for laboratory test use in the domains of inflammation, cardiology, hematology, nephrology and co-infection for clinicians managing the care of hospitalized CO...
Serum biochemical parameters as a surrogate marker for chest computed tomography in children with COVID-19 [0.03%]
血清生化指标作为COVID-19儿童胸部计算机断层扫描的替代标志物
Karuna M Das,Rajvir Singh,Sandeep Subramanya et al.
Karuna M Das et al.
Aim: This study aimed to investigate whether serum biochemical parameters can be used as a surrogate for chest computed tomography (CT) in the diagnosis of COVID-19 in pediatric patients. ...
mRNA-based COVID-19 vaccines appear not to increase immune events in cancer patients receiving immune checkpoint inhibitors [0.03%]
基于mRNA的COVID-19疫苗似乎不会增加接受免疫检查点抑制剂的癌症患者的免疫事件
Emre Yekedüz,Rüveyda Ayasun,Elif Berna Köksoy et al.
Emre Yekedüz et al.
Abhishesh Kumar Mehata,Matte Kasi Viswanadh,Vishnu Priya et al.
Abhishesh Kumar Mehata et al.
COVID-19 is an infectious and highly contagious disease caused by SARS-CoV-2. The immunotherapy strategy has a great potential to develop a permanent cure against COVID-19. Innate immune cells are in constant motion to scan molecular altera...
Molecular features and translational outlook for Epstein-Barr virus-associated gastric cancer [0.03%]
EB病毒相关胃癌的分子特征和转化前景
Lyla J Stanland,Micah A Luftig
Lyla J Stanland
Epstein-Barr Virus (EBV) was the first discovered human tumor virus and is the etiological agent of B cell lymphomas and also epithelial cancers. Indeed, nearly 10% of gastric cancers worldwide are EBV-positive and display unique molecular,...
Independent and incremental prognostic value of D-dimer in hospitalized COVID-19 patients [0.03%]
住院COVID-19患者的独立和增量预后价值-D二聚体检测法
Gerald Chi,Sahar Memar Montazerin,Jane J Lee
Gerald Chi
Potential drugs against COVID-19 revealed by gene expression profile, molecular docking and molecular dynamic simulation [0.03%]
基于基因表达谱、分子对接及分子动力学模拟的新冠肺炎潜在药物筛选
Claudia Cava,Gloria Bertoli,Isabella Castiglioni
Claudia Cava
Aim: SARS-CoV-2, an emerging betacoronavirus, is the causative agent of COVID-19. Currently, there are few specific and selective antiviral drugs for the treatment and vaccines to prevent contagion. However, their long-term effects can be r...
Marzieh Saei Ghare Naz,Mojdeh Banaei,Sareh Dashti et al.
Marzieh Saei Ghare Naz et al.
Aim: Sex differences in COVID-19 outcomes might be explained from a sex hormones (SexHs) perspective. Materials & methods: PubMed, Scopus, Web of Science, EMBASE and Google Scholar were searched up to March 2021. Results: Based on the liter...